Rightslink® by Copyright Clearance Center

Enhanced Versus Standard Dermatologic Management With Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC: The COCOON Global Randomized Controlled Trial

Author:

Byoung Chul Cho,Weimin Li,Alexander I. Spira,Maxwell Sauder,Jill Feldman,Farastuk Bozorgmehr,Milena Mak,Janellen Smith,Pei Jye Voon,Baogang Liu,Panwen Tian,Jiunn-Liang Tan,Cheng-Ta Yang,Jin-Yuan Shih,Nuri Karadurmus,Juan Esteban Cundom et al.

Publication:

Journal of Thoracic Oncology

Publisher:

Elsevier

Date:

October 2025

Please select your organization and/or account

Organization

Account

Please select your account from the above dropdown list. These accounts represent the offices, campuses, and other sites where your organization operates. Your account selection should match where you typically have an office or workspace. Even when you are traveling or temporarily working elsewhere, you should select the account that represents where you customarily work.

Cancel OK

Creative Commons

This is an open access article distributed under the terms of the license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article.